The HighWire with Del Bigtree — Episode 466 (March 5, 2026) opens with breaking legal and policy news: the Trump EPA has filed a brief at the U.S. Supreme Court backing Bayer/Monsanto and glyphosate (Roundup). Del breaks down what the government is arguing, what’s at stake for warning labels and litigation, and why the outcome could reshape corporate accountability around glyphosate-based herbicides.<br /><br />Then, Jefferey Jaxen covers the accelerating shift in public vaccine sentiment, as global vaccine uptake declines and pharmaceutical stocks react to falling demand. Del analyzes the latest reported data, including a major worldwide drop in Gardasil (HPV vaccine) uptake, and what these trends could signal for vaccine policy, mandates, and the future of the vaccine marketplace.<br /><br />Also, a dive into the growing national debate over vaccine manufacturer liability. New polling indicates strong public support for restoring legal accountability for vaccine makers, a key issue tied to vaccine injury protections, medical freedom, and federal vaccine policy.<br /><br />Plus, an in-studio scientific discussion you don’t want to miss: Del is joined by Dr. James Neuenschwander and Dr. Brian Hooker to break down a new study examining aluminum in vaccines and the potential implications for vaccine safety research, adverse event risk, and the broader childhood vaccination schedule.<br /><br />Become a supporter of this podcast: <a href="https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support?utm_source=rss&utm_medium=rss&utm_campaign=rss">https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support</a>.